Diabetes Therapy
Scope & Guideline
Innovating solutions for a healthier future in diabetes management.
Introduction
Aims and Scopes
- Clinical Trials and Interventions:
The journal frequently publishes results from randomized controlled trials and observational studies assessing the efficacy and safety of various diabetes treatments, including new pharmaceuticals, insulin therapies, and lifestyle interventions. - Real-World Evidence:
There is a consistent focus on real-world studies that evaluate treatment patterns, adherence, and outcomes among diverse populations, providing insights into how therapies perform outside of clinical trial settings. - Diabetes Complications and Management:
Research addressing the complications associated with diabetes, such as cardiovascular disease, diabetic kidney disease, and neuropathy, is a core area, emphasizing the need for comprehensive management strategies. - Innovative Technologies:
The journal highlights advancements in diabetes management technologies, such as continuous glucose monitoring systems and insulin delivery devices, which enhance patient care and glycemic control. - Psychosocial Aspects of Diabetes:
Studies exploring the psychological and social dimensions of living with diabetes, including patient-reported outcomes and quality of life, are integral to understanding the full impact of diabetes on individuals. - Ethnic and Regional Variations:
The journal frequently addresses variations in diabetes prevalence, treatment effectiveness, and health outcomes across different ethnic and regional populations, highlighting the need for tailored approaches.
Trending and Emerging
- GLP-1 Receptor Agonists and SGLT2 Inhibitors:
There is a marked increase in studies examining the efficacy, safety, and real-world applications of GLP-1 receptor agonists and SGLT2 inhibitors, which are becoming central to diabetes management. - Digital Health and Telemedicine:
Emerging research focuses on the use of digital health technologies, including mobile apps and telehealth services, to improve diabetes management and patient engagement, particularly in the context of the COVID-19 pandemic. - Personalized Medicine:
The trend towards personalized treatment approaches, including individualized therapy based on genetic, metabolic, and psychosocial factors, is gaining traction, reflecting a shift towards more tailored diabetes care. - Impact of COVID-19 on Diabetes Management:
Studies exploring the impact of the COVID-19 pandemic on diabetes care, including changes in treatment adherence and access to healthcare, are increasingly prevalent, highlighting the pandemic's lasting effects on chronic disease management. - Integrated Care Models:
Research on integrated care models that combine diabetes management with other chronic disease management, particularly cardiovascular and renal care, is emerging as a significant theme, emphasizing holistic patient approaches.
Declining or Waning
- Traditional Oral Hypoglycemic Agents:
Research related to older classes of oral hypoglycemic agents, such as sulfonylureas and thiazolidinediones, appears to be diminishing as newer classes like GLP-1 receptor agonists and SGLT2 inhibitors gain preference in clinical practice. - Basic Science Research:
There is a noticeable decline in papers focused on basic science and molecular mechanisms of diabetes, as the journal shifts towards more clinical and translational studies that impact patient care directly. - Long-Term Follow-Up Studies:
The frequency of long-term follow-up studies assessing the durability of diabetes interventions has decreased, likely due to the increasing demand for immediate clinical applicability and short-term outcomes. - Dietary Approaches to Diabetes:
Research focusing on traditional dietary interventions and their effects on diabetes management has waned, as more attention is given to pharmacological treatments and technology-based solutions. - Epidemiological Studies:
The publication of epidemiological studies that primarily focus on prevalence rates without exploring interventions or outcomes has seen a decline, as the journal emphasizes actionable research.
Similar Journals
DIABETES
Empowering research, enhancing patient outcomes.DIABETES, published by the American Diabetes Association, is a premier journal in the field of endocrinology, diabetes, and metabolism, renowned for its rigorous peer-reviewed research since its inception in 1952. With an impressive impact factor and classified in the Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine as of 2023, it holds a prestigious position within the scholarly community, ranked 17th out of 244 in its specialization. The journal's objective is to disseminate cutting-edge research and advance scientific understanding to ultimately improve diabetes patient care and management. While it does not offer open access options, the journal remains a vital resource for researchers, professionals, and students involved in diabetes-related studies. The ongoing dedication to excellence by the authors, reviewers, and editors ensures that DIABETES continues to be a pivotal platform for innovation and knowledge in the fight against diabetes.
Journal of Diabetology
Bridging research and practice in diabetes management.The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.
ACTA DIABETOLOGICA
Fostering Breakthroughs in Metabolic HealthACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.
DIABETES CARE
Elevating standards in diabetes and metabolic research.DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.
Primary Care Diabetes
Bridging the gap between research and real-world diabetes care.Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.
DIABETIC MEDICINE
Pioneering advancements in the understanding of diabetes mellitus.DIABETIC MEDICINE is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of endocrinology, specifically focusing on the pathophysiology, management, and prevention of diabetes mellitus and its complications. With an impressive impact factor reflecting its significant role in shaping clinical practice and research, DIABETIC MEDICINE holds a prominent position among its peers, categorized in the Q1 quartiles for Endocrinology, Diabetes and Metabolism, and Internal Medicine. Since its inception in 1984, the journal has provided a platform for rigorous and innovative research, fostering collaborative efforts among researchers, clinicians, and students to enhance diabetes care. The journal is esteemed for its high-ranking performance in Scopus, highlighted by its ranking of #33 in Internal Medicine and #64 in Endocrinology, Diabetes, and Metabolism. By offering insightful access to groundbreaking studies and reviews, DIABETIC MEDICINE plays a crucial role in informing policy and improving medical outcomes for individuals with diabetes, making it an essential resource for those in medical and clinical research fields.
Journal of Diabetes Investigation
Empowering discoveries in endocrinology and metabolism.Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.
Journal of Diabetes
Empowering discoveries in diabetes and metabolism.The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.
Diabetes Stoffwechsel und Herz
Pioneering Discussions on Diabetes and Cardiovascular RelationshipsDiabetes Stoffwechsel und Herz, published by VERLAG KIRCHHEIM, is a distinguished journal that focuses on the interdisciplinary field of diabetes research, cardiology, and metabolic disorders. With its dedicated approach, the journal aims to disseminate cutting-edge findings and foster innovative discussions among researchers and practitioners in the healthcare community. Despite its discontinuation in Scopus coverage since 2017, the journal continues to hold significance in advancing knowledge regarding the intricate relationship between diabetes and cardiovascular health. It offers researchers a platform to explore the biochemical, genetic, and clinical aspects of endocrinology, while also catering to the needs of professionals aiming to apply the latest research in their practice. The journal’s rankings, which place it in the lower percentiles across various relevant categories, reflect a unique opportunity for contributors looking to impact a niche yet vital area of medicine. As the field evolves, Diabetes Stoffwechsel und Herz remains committed to enriching the dialogue surrounding these critical health issues.
British Journal of Diabetes
Elevating the dialogue on diabetes prevention and management.The British Journal of Diabetes, published by the Association of British Clinical Diabetologists, is a premier journal dedicated to advancing the understanding, prevention, and management of diabetes. With an ISSN of 2397-6233, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that address the complexities of diabetes care and research. While currently not available as an open access option, the journal is committed to enhancing the visibility of cutting-edge diabetes research for healthcare professionals and academics. Located in the heart of England, this journal plays a crucial role in bridging the gap between clinical practice and research innovation, making it an essential resource for practitioners, researchers, and students alike. The British Journal of Diabetes is determined to contribute significantly to the global dialogue on diabetes, as it covers a wide spectrum of topics from epidemiology and public health to novel therapeutic strategies and patient management approaches.